Vaccine Market

Vaccine Market

A post by Blanche Scharf http://www.yourhealthupdates.com

I have been studying natural healing modalities for the last 25 years. In that time I have had the privilege of working with some of the greatest minds in Natural Healing including Naturopaths, Scientists, and Energy Healers. I have seen people miraculously heal from all kinds of dis-ease thru non-invasive methods. Personally, I have experienced all kinds of diets from Macrobiotics to Raw Foods. Now is a very important time to start sharing this health information with as many people as possible, so people can make well informed decisions about their health and not fall victim to a sickcare system based on profit, rather than one of supporting wholeness, compassion and love

To see more posts by Blanche Scharf, click here

A healthy vaccine market for the pharmaceutical companies is good for the economy and bad for us. Vaccines are emerging as one of the most lucrative segments for the pharmaceutical industry. With the future they predict for vaccines, we are slated to be pin cushions. The global vaccine market is expected to have revenues above the $34 billion mark by 2012. With that kind of money at stake, I say run for the hills. Remember to take your children with you. The pediatric markets are going to grow at a slow pace, but the teen market is the new focus.

This and the adult market will dominate the scene. The cancer vaccine market, led by cervical cancer vaccines, is presently one of the most lucrative areas for pharmaceutical companies. Too bad it is not helpful to our kids, and possibly dangerous. The new vaccines will be for addiction, cancer and proprietary pediatrics/adolescent vaccines. Do we have a vaccine for the pharmaceutical industries greed addiction?

The top four players accounted for about 74% of the total market in 2008. Now, pharmaceutical companies are pushing to improve technology, bolster production and ease public safety concerns over flu pandemics and viruses. In the late 1990’s, the number of seasonal flu vaccine manufactures fell to two, because  excess capacity caused prices to fall to about the $2-a-dose range. Today the almost useless flu dosages are in the $15 dollar range. Happy days are here for the pharmaceutical companies. Not so for us.

The vaccine market can reach $45 billion globally by 2015. Orders from around the world for H1N1 vaccine is in the billions of dollars. As flu strains mutate, vaccines will become part of the landscape. Baxter expects production of vaccines to combat the H1N1 Flu to continue indefinitely as the strains mutate. The fear that people have is that the market is too lucrative for honesty to prevail.

Trusting the pharmaceutical companies with your life is counterintuitive. The fact that profit is the motivating force makes for a bad partner. We are not sure of the world’s direction, but becoming a pin cushion does not sound like a good idea. Our children are paying the price for this experiment. At this point it is a shot in the dark, we do not know if we are really averting anything. The ramifications to having all this vile stuff being injected into us are not known. It will be years before we see what was done in the name of science.

The vaccines have been a shot in the arm for the pharmaceutical manufactures, but for us it can turn out to be the biggest pain in the butt. This is what a forecast report includes: Global Revenues is a word that appears over and over in inside reports on the outlook for the industry. A healthy vaccine market may be our downfall

Share and Enjoy:
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market
  • Vaccine Market

Related posts:

Leave a Reply